S.Amdt. 3350Senate114th Congress (2015-2017)
S.Amdt. 3350
Sponsored by
Sen. Brian Schatz (D-HI)
Submitted February 29, 2016
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
February 29, 2016
View full timeline
Floor
Senate amendment submitted
February 29, 2016
Floor
Senate amendment submitted
February 29, 2016
Text
Submitted
SA 3350. Mr. SCHATZ (for himself and Mr. Hatch) submitted an amendment intended to be proposed by him to the bill S. 524, to authorize the Attorney General to award grants to address the national epidemics of prescription opioid abuse and heroin use; which was ordered to lie on the table; as follows: At the end of title I of the bill, add the following: SEC. 104. ENHANCING BASIC AND APPLIED RESEARCH ON PAIN TO DISCOVER THERAPIES TO REDUCE THE CURRENT OVER- PRESCRIBING OF OPIOIDS. (a) In General.--The Director of the National Institutes of Health may intensify and coordinate fundamental, translational, and clinical research of the National Institutes of Health (referred to in this section as the ``NIH'') with respect to the understanding of pain and the discovery and development of therapies for chronic pain. (b) Priority and Direction.--The prioritization and direction of the Federally funded portfolio of pain research studies shall consider recommendations made by the Interagency Pain Research Coordinating Committee in concert with the Pain Management Best Practices Inter-Agency Task Force, and in accordance with the National Pain Strategy, the Federal Pain Research Strategy, and the NIH-Wide Strategic Plan for Fiscal Years 2016-2020, the latter which calls for the relative burdens of individual diseases and medical disorders to be regarded as crucial considerations in balancing the priorities of the Federal research portfolio. (c) Funding.--Funds shall be available to carry out this section from funds otherwise available to the NIH. ____________________